Luxembourg: Difference between revisions
| Line 31: | Line 31: | ||
Bladder, urethra, ureters and renal pelvis: pTa non-invasive papillary carcinoma; low-grade mucinous neoplasia limited to the appendix (LAMN); | Bladder, urethra, ureters and renal pelvis: pTa non-invasive papillary carcinoma; low-grade mucinous neoplasia limited to the appendix (LAMN); | ||
gastro-intestinal stroma tumors). High-grade intraepithelial neoplasia of the cervix, vulva, vagina, penis, prostate, and anus are also recorded. | gastro-intestinal stroma tumors). High-grade intraepithelial neoplasia of the cervix, vulva, vagina, penis, prostate, and anus are also recorded. | ||
'''Data access:''' To request access to restricted data, it is necessary to follow the procedures indicated in "Annex 2" of the document "Procedures for disclosure of results", available on [https://www.rnc.lu/M%c3%a9thodologie/Diffusion-des-r%c3%a9sultats this] website. | |||
'''Open data access:''' | '''Open data access:''' | ||
Revision as of 18:38, 18 May 2023
Cancer Centers
Healthcare System
Administrative or Claims Data
Registries
Database: National Register of Cancer (RNC)
Sponsor, manager or home institution: The National Minister of Health and the Center of Expertise in Public Health (Department of Population Health of the Luxembourg Institute of Health).
Primary purpose: Collects information from all the new cases of cancer that have been diagnosed and/or treated in the Luxembourg territory (includes information about residents and non-residents of the country). With this data, it is possible to monitor and enhance the quality of care and epidemiological surveillance.
Type of information: Type of information RNC - Luxembourg
Available type of information:
Source of Information: Main sources - Hospital Cancer Registries, and the National Health Laboratory; Auxiliary sources - National cancer screening programs (breast cancer, colorectal, other national cancer screening programs), Social Security Medical Control, the National Health Fund, the Common Health Insurance Scheme of the European Communities (JSIS), the Directorate of Health: Death certificates, Civil Registry, Private medical analysis laboratories.
Data level: Patient-level.
Available data level:
Number of Records:
Date Range: 2013 onwards.
Cancer Areas of Interest: All primary in situ and invasive tumors are recorded, including hematological malignancies; For benign tumors or tumors with uncertain evolution, only the following tumors are recorded (benign tumors with uncertain evolution of central nervous system and intracerebral endocrine glands; thymomas; ovarians borderline tumors; invasive hydatidiform mole (placenta tumor); Bladder, urethra, ureters and renal pelvis: pTa non-invasive papillary carcinoma; low-grade mucinous neoplasia limited to the appendix (LAMN); gastro-intestinal stroma tumors). High-grade intraepithelial neoplasia of the cervix, vulva, vagina, penis, prostate, and anus are also recorded.
Data access: To request access to restricted data, it is necessary to follow the procedures indicated in "Annex 2" of the document "Procedures for disclosure of results", available on this website.
Open data access:
Information/Contact for data request: Contact information
